Impaired capacity for endogenous fibrinolysis in essential hypertension.
Hrafnkelsdóttir
T
T
Wall
U
U
Jern
C
C
Jern
S
S
D000328:Adult; D016022:Case-Control Studies; D003328:Coronary Thrombosis / Q000209:etiology; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D005342:Fibrinolysis; D005542:Forearm / Q000098:blood supply; D006490:Hemostatics / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000378:metabolism*; D007261:Infusions, Intra-Arterial; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D008875:Middle Aged; D010277:Parasympathomimetics / Q000494:pharmacology; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D006490:Hemostatics; D010277:Parasympathomimetics; D017395:Plasminogen Activator Inhibitor 1; D016210:Methacholine Chloride; D010959:Tissue Plasminogen Activator; D003894:Deamino Arginine Vasopressin